Mid-Atlantic Protein & Biotech User Meetings
April 2018 Meeting was held in Princeton, NJ
Speakers
- Bhumit Patel, Merck and Co. Inc.
"Multi Angle Light Scattering as a Process Analytical Technology To Determine Real Time Molecular Weight For Downstream Process Control" - Sina Mortazavi and Nestor Concha, GlaxoSmithKline
"Assays to Improve Protein Stability"
April 2017 Meeting was held in Princeton, NJ
Speakers
- Kushol Gupta, University of Pennsylvania
"Biophysical Studies of Protein Drug Targets" - Bob Collins, Wyatt Technology
"DLS: Theory and Survey of Applications" - Danhui Sun/Eric Seymour, Wyatt Technology
"MALS: Theory and Survey of Hyphenated Methods SEC-, FFF- and CG-MALS" - Eric Seymour, Wyatt Technology
"Diffusion Interation Parameter: What, How, Why?" - Danhui Sun, Wyatt Technology
"Glycosolated Protein Analytsis: Limitations and Capabilities of SEC-MALS"
April 2015 Meeting was held in Princeton, NJ
Speakers
- Kushol Gupta, University of Pennsylvania
"Lasers and X-rays and Neutrons (oh my!): Applications of Scattering to Structural Biology" - Steven Labrenz, Drug Product Development, Janssen R&D, LLC.
"Colloidal Stability Modeling in mAb Formulation Development" - Stacy Spencer, Analytical Discovery within Biologics Research, Janssen R&D, LLC.
"mAb Comparability using Protein-Protein Interactions via Dynamic Light Scattering" - Emily Wen, Merck & Co.
"Process Development of a Polysaccharide-Protein Conjugate Vaccine using HPSEC/MALS/RI"
November 2013 Meeting was held in Princeton, NJ
Speakers
- Haripada Maity, ImClone Systems, a wholly-owned subsidiary of Eli Lilly & Company
"Overcoming Challenges in Protein Formulation Development and Downstream Process Optimization using Light Scattering and Other Biophysical Techniques" - Lumelle Schneeweis, Bristol-Myers Squibb Inc.
"Size, Shape, and Composition of Higher-Order Protein Structure" - John Champagne, Wyatt Technology
"VLP Characterization: Molar Mass, Size, Composition, Conformation and Interactions" - Daniel Some, Wyatt Technology
"CG-MALS Case Study: Multi-Valent Protein Ligand Binding" and
"Novel DLS Analyses for Biotherapeutic Developability and Formulation Screening"
Follow us on or join one of our groups Social@Wyatt